Intellia Therapeutics, Inc. (NTLA) insider trading.
In Q3 2026, insiders at Intellia Therapeutics, Inc. reported 5 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $507K.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 5
- Net shares, P minus S
- -38,104
- Insiders
- 3
- Last filed
- 2026-08-24
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Leonard John M | Director, Officer · President and CEO | 2 | 0 | 2 |
| Dulac Edward J III | Officer · EVP, Chief Financial Officer | 2 | 0 | 2 |
| Dube Michael P | Officer · VP, Chief Accounting Officer | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-21 | Leonard John M | S (D) | 2,785 | $13 | 1,147,064 | Form 4 |
| 2026-08-20 | Leonard John M | S (D) | 19,890 | $12.6 | 1,149,849 | Form 4 |
| 2026-07-22 | Dulac Edward J III | S (D) | 8,111 | $11.25 | 148,175 | Form 4 |
| 2026-07-02 | Dulac Edward J III | S (D) | 4,677 | $18 | 156,286 | Form 4 |
| 2026-07-01 | Dube Michael P | S (D) | 2,641 | $16.78 | 66,886 | Form 4 |
Transaction codes in this quarter
Get NTLA insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1652130&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · NTLA company page · Intellia Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Intellia Therapeutics, Inc. (NTLA)?
In Q3 2026, insiders at Intellia Therapeutics, Inc. reported 5 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $507K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Intellia Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/ntla.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.